Effects of Azacitidine (AZA) Vs Conventional Care Regimens (CCR) in Elderly (≥75 years) Patients (Pts) with Myelodysplastic Syndromes (MDS) from the AZA-001 Survival Trial / John F Seymour, Pierre Fenaux, Lewis B. Silverman, Ghulam J Mufti, Eva Hellström-Lindberg, Valeria Santini, Alan F. List, Steven D. Gore, Jay Backstrom, David McKenzie, and C. L. Beach. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 112:(2008), pp. 3629-3629. (ASH san francisco 6-9 dicembre 2008).
Effects of Azacitidine (AZA) Vs Conventional Care Regimens (CCR) in Elderly (≥75 years) Patients (Pts) with Myelodysplastic Syndromes (MDS) from the AZA-001 Survival Trial
SANTINI, VALERIA;
2008
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
